What is the price target for BBNX stock?
18 analysts have analysed BBNX and the average price target is 23.89 USD. This implies a price increase of 169.58% is expected in the next year compared to the current price of 8.86.
NASDAQ:BBNX • US08659B1026
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BETA BIONICS INC (BBNX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-09 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-02-18 | Stifel | Maintains | Buy -> Buy |
| 2026-02-18 | Baird | Maintains | Neutral -> Neutral |
| 2026-02-04 | Stifel | Maintains | Buy -> Buy |
| 2026-02-02 | Truist Securities | Maintains | Buy -> Buy |
| 2026-01-27 | TD Cowen | Initiate | Hold |
| 2026-01-09 | Lake Street | Maintains | Buy -> Buy |
| 2026-01-05 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-29 | Stifel | Reiterate | Buy -> Buy |
| 2025-10-29 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-10-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-29 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-21 | Stifel | Reiterate | Buy |
| 2025-10-01 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-09-22 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-30 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-30 | Baird | Maintains | Neutral -> Neutral |
| 2025-06-16 | Truist Securities | Initiate | Buy |
| 2025-05-30 | Wolfe Research | Initiate | Outperform |
| 2025-05-30 | Goldman Sachs | Initiate | Neutral |
| 2025-02-24 | Leerink Partners | Initiate | Outperform |
| 2025-02-24 | Lake Street | Initiate | Buy |
| 2025-02-24 | Stifel | Initiate | Buy |
| 2025-02-24 | Piper Sandler | Initiate | Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.995M 6,601.12% | 65.124M 442.93% | 100.251M 53.94% | 135.24M 34.90% | 182.07M 34.63% | 255.3M 40.22% | 357.05M 39.86% | 460.07M 28.85% | 517.14M 12.40% | 634.44M 22.68% | |
| EBITDA YoY % growth | -34.624M 46.32% | -44.1M -27.37% | -70.108M -58.98% | -71.555M -2.06% | -69.372M 3.05% | -42.088M 39.33% | -33.15M 21.24% | -10.608M 68.00% | N/A | N/A | |
| EBIT YoY % growth | -35.85M 45.55% | -45.251M -26.22% | -71.681M -58.41% | -98.423M -37.31% | -99.754M -1.35% | -81.245M 18.56% | -60.18M 25.93% | -25.5M 57.63% | 52.02M 304.00% | 68.34M 31.37% | |
| Operating Margin | -298.87% | -69.48% | -71.50% | -72.78% | -54.79% | -31.82% | -16.85% | -5.54% | 10.06% | 10.77% | |
| EPS YoY % growth | N/A | N/A | -1.94 8.78% | -1.95 -0.29% | -1.95 -0.44% | -1.33 31.77% | -1.93 -44.59% | -1.51 21.69% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.50 46.41% | -0.51 -29.67% | -0.48 -44.13% | -0.47 -63.06% | -0.48 3.53% | -0.47 6.55% | -0.47 1.57% | -0.48 -2.24% | -0.18 61.81% | -0.19 58.99% | -0.15 67.32% | -0.12 74.68% |
| Revenue Q2Q % growth | 27.504M 55.93% | 32.144M 38.33% | 35.526M 30.36% | 39.983M 24.48% | 38.284M 39.19% | 42.827M 33.23% | 47.582M 33.94% | 53.834M 34.64% | 57.13M 49.23% | 61.241M 43.00% | 66.341M 39.42% | 72.593M 34.85% |
| EBITDA Q2Q % growth | -20.166M -9.96% | -19.153M 0.36% | -16.672M -4.15% | -15.73M -8.10% | -15.546M 22.91% | -15.601M 18.55% | -16.242M 2.58% | -17.376M -10.47% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -25.396M -36.23% | -25.537M -28.51% | -24.08M -41.29% | -23.684M -46.89% | -23.358M 8.03% | -24.089M 5.67% | -23.381M 2.90% | -24.027M -1.45% | -11.159M 52.23% | -11.873M 50.71% | -9.578M 59.04% | -7.844M 67.35% |
All data in USD
18 analysts have analysed BBNX and the average price target is 23.89 USD. This implies a price increase of 169.58% is expected in the next year compared to the current price of 8.86.
BETA BIONICS INC (BBNX) will report earnings on 2026-04-21.
The consensus EPS estimate for the next earnings of BETA BIONICS INC (BBNX) is -0.5 USD and the consensus revenue estimate is 27.50M USD.
The consensus rating for BETA BIONICS INC (BBNX) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.